In a human randomized, double-blind, placebo-controlled pilot trial, LIPUS-treated participants showed a trend toward reduced worsening of ADAS-J cog scores at 72 weeks, warranting further evaluation [ 100 ].
1
—
—
In a human randomized, double-blind, placebo-controlled pilot trial, LIPUS-treated participants showed a trend toward reduced worsening of ADAS-J cog scores at 72 weeks, warranting further evaluation [ 100 ].